Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Klein

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Clinical Pharmacology and Therapeutics|July 2, 2016
Novel Disease-Drug Database Demonstrating Applicability for Pharmacogenomic-Based PrescribingM Whirl-Carrillo, K Sangkuhl, L Gong, et al.
Biochimica Et Biophysica Acta|April 19, 1990
The structure-activity relationship of the papain hydrolysis of N-benzoylglycine estersC M Compadre, C Hansch, T E Klein, et al.
Chemico-Biological Interactions|January 1, 1988
QSAR analysis of the subtilisin hydrolysis of X-phenyl hippurates. II. A study of subtilisin BPN'A Carotti, C Raguseo, T E Klein, et al.
Clinical Pharmacology and Therapeutics|September 2, 2011
Pharmacogenetics: call to actionM V Relling, H J Guchelaar, D M Roden, et al.
Biopolymers|February 13, 2001
Computed free energy differences between point mutations in a collagen-like peptideS D Mooney, C C Huang, P A Kollman, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Enabling the curation of your pharmacogenetic studyE m McDonagh, M Whirl-Carrillo, R B Altman, et al.
Biochemistry|July 28, 1987
Photoaffinity analogues of methotrexate as folate antagonist binding probes. 1. Photoaffinity labeling of murine L1210 dihydrofolate reductase and amino acid sequence of the binding regionE M Price, P L Smith, T E Klein, et al.
Journal of Medicinal Chemistry|October 23, 1998
Quantitative structure-activity relationships of 2, 4-diamino-5-(2-X-benzyl)pyrimidines versus bacterial and avian dihydrofolate reductaseC D Selassie, W X Gan, L S Kallander, et al.
Protein Science : a Publication of the Protein Society|May 25, 1999
Macromolecular docking of a three-body system: the recognition of human growth hormone by its receptorD K Hendrix, T E Klein, I D Kuntz, et al.
Clinical Pharmacology and Therapeutics|April 30, 2017
Response to "Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped" - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of VoriconazoleT J Walsh, B Moriyama, S R Penzak, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|July 2, 2016
Novel Disease-Drug Database Demonstrating Applicability for Pharmacogenomic-Based PrescribingM Whirl-Carrillo, K Sangkuhl, L Gong, et al.
Biochimica Et Biophysica Acta|April 19, 1990
The structure-activity relationship of the papain hydrolysis of N-benzoylglycine estersC M Compadre, C Hansch, T E Klein, et al.
Chemico-Biological Interactions|January 1, 1988
QSAR analysis of the subtilisin hydrolysis of X-phenyl hippurates. II. A study of subtilisin BPN'A Carotti, C Raguseo, T E Klein, et al.
Clinical Pharmacology and Therapeutics|September 2, 2011
Pharmacogenetics: call to actionM V Relling, H J Guchelaar, D M Roden, et al.
Biopolymers|February 13, 2001
Computed free energy differences between point mutations in a collagen-like peptideS D Mooney, C C Huang, P A Kollman, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Enabling the curation of your pharmacogenetic studyE m McDonagh, M Whirl-Carrillo, R B Altman, et al.
Biochemistry|July 28, 1987
Photoaffinity analogues of methotrexate as folate antagonist binding probes. 1. Photoaffinity labeling of murine L1210 dihydrofolate reductase and amino acid sequence of the binding regionE M Price, P L Smith, T E Klein, et al.
Journal of Medicinal Chemistry|October 23, 1998
Quantitative structure-activity relationships of 2, 4-diamino-5-(2-X-benzyl)pyrimidines versus bacterial and avian dihydrofolate reductaseC D Selassie, W X Gan, L S Kallander, et al.
Protein Science : a Publication of the Protein Society|May 25, 1999
Macromolecular docking of a three-body system: the recognition of human growth hormone by its receptorD K Hendrix, T E Klein, I D Kuntz, et al.
Clinical Pharmacology and Therapeutics|April 30, 2017
Response to "Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped" - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of VoriconazoleT J Walsh, B Moriyama, S R Penzak, et al.
Pageof 7